Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Correlates of cognitive impairment in first episode schizophrenia: the EUFEST study.

Galderisi S, Davidson M, Kahn RS, Mucci A, Boter H, Gheorghe MD, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Fleischhacker WW; EUFEST group.

Schizophr Res. 2009 Dec;115(2-3):104-14. doi: 10.1016/j.schres.2009.09.022. Epub 2009 Oct 12.

PMID:
19822407
2.

Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study.

Wobrock T, Falkai P, Schneider-Axmann T, Hasan A, Galderisi S, Davidson M, Kahn RS, Derks EM, Boter H, Rybakowski JK, Libiger J, Dollfus S, López-Ibor JJ, Peuskens J, Hranov LG, Gaebel W, Fleischhacker WW; EUFEST study group.

Schizophr Res. 2013 Jun;147(1):132-139. doi: 10.1016/j.schres.2013.03.001. Epub 2013 Mar 26.

PMID:
23537477
3.

[Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].

Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B.

Encephale. 2008 Dec;34(6):557-62. doi: 10.1016/j.encep.2007.12.005. Epub 2008 Jul 9. French.

PMID:
19081451
4.

Profiling cognitive impairment in treatment-resistant schizophrenia patients.

Frydecka D, Beszłej JA, Gościmski P, Kiejna A, Misiak B.

Psychiatry Res. 2016 Jan 30;235:133-8. doi: 10.1016/j.psychres.2015.11.028. Epub 2015 Nov 18.

PMID:
26706131
5.

Impacts of duration of untreated psychosis on cognition and negative symptoms in first-episode schizophrenia: a 3-year prospective follow-up study.

Chang WC, Hui CL, Tang JY, Wong GH, Chan SK, Lee EH, Chen EY.

Psychol Med. 2013 Sep;43(9):1883-93. doi: 10.1017/S0033291712002838. Epub 2012 Dec 7.

PMID:
23217676
6.

Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia: is it a practice effect?

Goldberg TE, Goldman RS, Burdick KE, Malhotra AK, Lencz T, Patel RC, Woerner MG, Schooler NR, Kane JM, Robinson DG.

Arch Gen Psychiatry. 2007 Oct;64(10):1115-22.

PMID:
17909123
7.

Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis.

Ayesa-Arriola R, Pérez-Iglesias R, Rodríguez-Sánchez JM, Pardo-García G, Tabares-Seisdedos R, Ayuso-Mateos JL, Vázquez-Barquero JL, Crespo-Facorro B.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:23-8. doi: 10.1016/j.pnpbp.2012.11.012. Epub 2012 Dec 7.

PMID:
23228461
8.

Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).

Davidson M, Galderisi S, Weiser M, Werbeloff N, Fleischhacker WW, Keefe RS, Boter H, Keet IP, Prelipceanu D, Rybakowski JK, Libiger J, Hummer M, Dollfus S, López-Ibor JJ, Hranov LG, Gaebel W, Peuskens J, Lindefors N, Riecher-Rössler A, Kahn RS.

Am J Psychiatry. 2009 Jun;166(6):675-82. doi: 10.1176/appi.ajp.2008.08060806. Epub 2009 Apr 15. Erratum in: Am J Psychiatry. 2009 Jun;166(6):731.

PMID:
19369319
9.

No sex differences in neuropsychological performance in first episode psychosis patients.

Ayesa-Arriola R, Rodriguez-Sanchez JM, Gomez-Ruiz E, Roiz-Santiáñez R, Reeves LL, Crespo-Facorro B.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:149-54. doi: 10.1016/j.pnpbp.2013.09.009. Epub 2013 Sep 25.

PMID:
24075821
10.

[Schizophrenic disorders--does cognitive dysfunction relate to characteristics of course and psychopathology of the illness?].

Wciórka J, Bembenek A, Hintze B, Kühn-Dymecka A.

Psychiatr Pol. 2006 Sep-Oct;40(5):867-84. Polish.

PMID:
17217232
11.

Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.

Galderisi S, Mucci A, Bitter I, Libiger J, Bucci P, Fleischhacker WW, Kahn RS; Eufest Study Group.

Eur Neuropsychopharmacol. 2013 Mar;23(3):196-204. doi: 10.1016/j.euroneuro.2012.04.019. Epub 2012 May 28.

PMID:
22647933
12.

Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial.

Harvey PD, Rabinowitz J, Eerdekens M, Davidson M.

Am J Psychiatry. 2005 Oct;162(10):1888-95.

PMID:
16199835
13.

The cognitive profile of aripiprazole differs from that of other atypical antipsychotics in schizophrenia patients.

Hori H, Yoshimura R, Katsuki A, Hayashi K, Ikenouchi-Sugita A, Umene-Nakano W, Nakamura J.

J Psychiatr Res. 2012 Jun;46(6):757-61. doi: 10.1016/j.jpsychires.2012.02.013. Epub 2012 Mar 29.

PMID:
22464338
14.

Relationship between diminished expression and cognitive impairment in first-episode schizophrenia: a prospective three-year follow-up study.

Chang WC, Hui CL, Chan SK, Lee EH, Wong GH, Chen EY.

Schizophr Res. 2014 Jan;152(1):146-51. doi: 10.1016/j.schres.2013.11.027. Epub 2013 Dec 12.

PMID:
24333004
15.

Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.

Kim SW, Shin IS, Kim JM, Lee SH, Lee YH, Yang SJ, Yoon JS.

Hum Psychopharmacol. 2009 Oct;24(7):565-73. doi: 10.1002/hup.1057.

PMID:
19790174
16.

Cognitive neuropsychological functioning in New Zealand Māori diagnosed with schizophrenia.

Kake TR, Garrett N, Te Aonui M.

Aust N Z J Psychiatry. 2016 Jun;50(6):566-76. doi: 10.1177/0004867415607986. Epub 2015 Oct 22.

PMID:
26494850
17.

Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.

Cuesta MJ, Sánchez-Torres AM, Cabrera B, Bioque M, Merchán-Naranjo J, Corripio I, González-Pinto A, Lobo A, Bombín I, de la Serna E, Sanjuan J, Parellada M, Saiz-Ruiz J, Bernardo M; PEPs Group.

Schizophr Res. 2015 May;164(1-3):65-73. doi: 10.1016/j.schres.2015.02.022. Epub 2015 Mar 26.

PMID:
25819935
18.

Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia.

Hou CL, Xiang YT, Wang ZL, Everall I, Tang Y, Yang C, Xu MZ, Correll CU, Jia FJ.

Schizophr Res. 2016 Jul;174(1-3):71-76. doi: 10.1016/j.schres.2016.04.034. Epub 2016 May 16.

PMID:
27197904
19.

Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia.

Ho BC, Alicata D, Ward J, Moser DJ, O'Leary DS, Arndt S, Andreasen NC.

Am J Psychiatry. 2003 Jan;160(1):142-8.

PMID:
12505813
20.

Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia.

F Egan M, Zhao X, Gottwald R, Harper-Mozley L, Zhang Y, Snavely D, Lines C, Michelson D.

Schizophr Res. 2013 May;146(1-3):224-30. doi: 10.1016/j.schres.2013.02.030. Epub 2013 Mar 22.

PMID:
23523692

Supplemental Content

Support Center